Showing results (91-100 of 134) with videos related to

Sort By:
Pageof 14
Infection and Immunity|May 11, 1992
Monoclonal antibody against Klebsiella capsular polysaccharide reduces severity and hematogenic spread of experimental Klebsiella pneumoniae pneumoniaT K Held, M Trautmann, M E Mielke, et al.
The Journal of Infectious Diseases|May 11, 1991
Production and characterization of a human hyperimmune intravenous immunoglobulin against Pseudomonas aeruginosa and Klebsiella speciesS J Cryz, E Fürer, J C Sadoff, et al.
The Journal of Infectious Diseases|October 1, 1994
Safety and immunogenicity of a polyvalent Escherichia coli vaccine in human volunteersA Cross, A Artenstein, J Que, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1993
Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremiaA Brauner, S J Cryz, M Granström, et al.
Developments in Biological Standardization|January 11, 1990
Human monoclonal antibodies to Pseudomonas aeruginosa type-specific lipopolysaccharides, toxin A and Klebsiella capsular polysaccharidesA B Lang, E Fürer, U Schürch, et al.
The Journal of Infectious Diseases|May 11, 1991
Safety and immunogenicity of Escherichia coli O18 O-specific polysaccharide (O-PS)-toxin A and O-PS-cholera toxin conjugate vaccines in humansS J Cryz, A S Cross, J C Sadoff, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1991
Human monoclonal antibodies specific for capsular polysaccharides of Klebsiella recognize clusters of multiple serotypesA B Lang, U Bruderer, G Senyk, et al.
Behring Institute Mitteilungen|February 1, 1997
Immunization of cystic fibrosis patients with a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccineS J Cryz, A Lang, A Rüdeberg, et al.
The Journal of Infectious Diseases|March 18, 2000
Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvantR Glück, R Mischler, P Durrer, et al.
The Journal of Infectious Diseases|August 11, 1992
Affinity constants of naturally acquired and vaccine-induced anti-Pseudomonas aeruginosa antibodies in healthy adults and cystic fibrosis patientsU Bruderer, S J Cryz, U B Schaad, et al.
Pageof 14